Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities
- Pavlina Sverak
- , Meredith E. Adams
- , Stephen J. Haines
- , Samuel C. Levine
- , David Nascene
- , Katherine Sommer
- , Kathryn Dusenbery
- , Tina C. Huang
- , Christopher Moertel
Research output: Contribution to journal › Article › peer-review
27
Link opens in a new tab
Scopus
citations